Baolingbao Biology Co Ltd Cash Flow Reinvestment Rate
Baolingbao Biology Co Ltd cash flow reinvestment rate. Baolingbao Biology Co Ltd (002286) has a Cash Flow Reinvestment Rate of 0.31x as of September 2025, reinvesting CN¥42.30 Million (capex CN¥42.30 Million ) from operating cash flow of CN¥134.96 Million. Explore how well can Baolingbao Biology Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Baolingbao Biology Co Ltd (2006–2025)
Cash flow reinvestment rate of Baolingbao Biology Co Ltd from 2006 to 2025. Historical reinvestment intensity for Baolingbao Biology Co Ltd across 19 annual periods. Explore capital reinvestment ratio of Baolingbao Biology Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Baolingbao Biology Co Ltd Cash Flow Reinvestment Rate by Year (2006–2025)
Baolingbao Biology Co Ltd cash flow reinvestment rate by year from 2006 to 2025. Year-by-year capital reinvestment analysis for Baolingbao Biology Co Ltd. For the full cash flow conversion analysis, see 002286 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.06x | CN¥274.80 Million | CN¥259.36 Million | CN¥189.30 Million | ▲ +19.5% |
| 2024 | 0.89x | CN¥220.53 Million | CN¥248.72 Million | CN¥189.93 Million | ▼ -16.7% |
| 2023 | 1.06x | CN¥300.33 Million | CN¥282.28 Million | CN¥152.23 Million | ▼ -91.2% |
| 2022 | 12.14x | CN¥374.04 Million | CN¥30.82 Million | CN¥254.55 Million | ▲ +1199.7% |
| 2021 | 0.93x | CN¥192.60 Million | CN¥206.27 Million | CN¥92.85 Million | ▲ +162.0% |
| 2020 | 0.36x | CN¥141.98 Million | CN¥398.46 Million | CN¥131.93 Million | ▼ -61.5% |
| 2019 | 0.92x | CN¥142.40 Million | CN¥153.95 Million | CN¥95.46 Million | ▼ -57.5% |
| 2018 | 2.17x | CN¥289.31 Million | CN¥133.05 Million | CN¥173.71 Million | ▲ +117.8% |
| 2016 | 1.00x | CN¥108.81 Million | CN¥108.98 Million | CN¥96.53 Million | ▼ -81.7% |
| 2015 | 5.46x | CN¥422.83 Million | CN¥77.49 Million | CN¥199.40 Million | ▲ +103.5% |
| 2014 | 2.68x | CN¥272.91 Million | CN¥101.77 Million | CN¥272.91 Million | ▲ +55.7% |
| 2013 | 1.72x | CN¥147.47 Million | CN¥85.60 Million | CN¥147.47 Million | ▲ +140.3% |
| 2012 | 0.72x | CN¥67.50 Million | CN¥94.15 Million | CN¥67.50 Million | ▼ -7.0% |
| 2011 | 0.77x | CN¥132.31 Million | CN¥171.70 Million | CN¥132.31 Million | ▼ -86.8% |
| 2010 | 5.86x | CN¥160.82 Million | CN¥27.45 Million | CN¥160.82 Million | ▲ +178.9% |
| 2009 | 2.10x | CN¥93.51 Million | CN¥44.51 Million | CN¥93.51 Million | ▲ +234.8% |
| 2008 | 0.63x | CN¥69.51 Million | CN¥110.77 Million | CN¥69.51 Million | ▼ -78.6% |
| 2007 | 2.93x | CN¥231.69 Million | CN¥78.98 Million | CN¥231.69 Million | ▲ +285.3% |
| 2006 | 0.76x | CN¥14.56 Million | CN¥19.12 Million | CN¥14.56 Million | — |